STOCK TITAN

Amgen (AMGN) EVP Jonathan Graham reports 1,257 tax-withheld shares at $329.82

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Amgen Inc. executive vice president and general counsel Jonathan P. Graham reported two routine tax-related share dispositions. On May 2, 2026, a total of 1,257 shares of Amgen common stock were withheld at $329.82 per share to satisfy tax obligations on equity awards, rather than sold on the open market. Following these transactions, his reported direct holdings in the affected accounts were 38,010 and 38,620 shares of common stock.

Positive

  • None.

Negative

  • None.
Insider Graham Jonathan P
Role EVP & Gen. Counsel & Sec.
Type Security Shares Price Value
Tax Withholding Common Stock 647 $329.82 $213K
Tax Withholding Common Stock 610 $329.82 $201K
Holdings After Transaction: Common Stock — 38,620 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Tax-withheld shares 1,257 shares Total F-code tax-withholding dispositions on May 2, 2026
First tax-withholding lot 610 shares Common stock withheld at $329.82 per share
Second tax-withholding lot 647 shares Common stock withheld at $329.82 per share
First post-transaction holding 38,010 shares Direct common stock holding after one F-code transaction
Second post-transaction holding 38,620 shares Direct common stock holding after the other F-code transaction
Tax-withholding price $329.82 per share Value used for both F-code dispositions
Dividend Equivalents credited 395 DEs Credited to unvested RSUs under Amgen 2009 Equity Incentive Plan
tax-withholding disposition financial
"transaction_action: tax-withholding disposition for both F-code entries"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Restricted Stock Units financial
"DEs are credited to the reporting person's unvested Restricted Stock Units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Dividend Equivalents financial
"These shares include 395 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended"
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
dividend reinvestment plan financial
"subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's"
A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Graham Jonathan P

(Last)(First)(Middle)
ONE AMGEN CENTER DRIVE

(Street)
THOUSAND OAKS CALIFORNIA 91320-1799

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP & Gen. Counsel & Sec.
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/02/2026F647D$329.8238,620D
Common Stock05/02/2026F610D$329.8238,010(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares include 395 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
/s/ Jonathan P. Graham05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Amgen (AMGN) executive Jonathan P. Graham report in this Form 4 filing?

Jonathan P. Graham reported two tax-withholding dispositions totaling 1,257 shares of Amgen common stock. Shares were withheld at $329.82 per share to cover tax liabilities tied to equity awards, rather than being sold in open-market transactions.

How many Amgen (AMGN) shares were withheld for Jonathan P. Graham’s taxes and at what price?

A total of 1,257 Amgen common shares were withheld to satisfy tax obligations. The dispositions occurred at a reported price of $329.82 per share, reflecting the value used for the tax-withholding calculation on the underlying equity compensation.

Were Jonathan P. Graham’s Amgen (AMGN) transactions open-market sales?

No. Both transactions were coded “F,” indicating tax-withholding dispositions, not open-market sales. Shares were delivered back to the company to pay tax liabilities arising from equity compensation, a common administrative mechanism rather than a discretionary share sale.

What are Jonathan P. Graham’s reported Amgen (AMGN) share holdings after these transactions?

After the tax-withholding dispositions, the filing shows direct holdings of 38,010 shares in one account and 38,620 shares in another. These figures reflect his post-transaction ownership positions for the specific awards referenced in the reported Form 4 transactions.

What does the footnote about Dividend Equivalents mean for Amgen (AMGN) shares?

The footnote explains that 395 Dividend Equivalents are credited to Jonathan P. Graham’s unvested Restricted Stock Units. These DEs convert to Amgen common shares on a one-to-one basis as the RSUs vest, with any fractional share paid out in cash, enhancing future share payouts.